ReShape also provided an update on the asset purchase agreement with Biorad Medisys. On July 9, 2024, ReShape Lifesciences Inc. entered into a definitive merger agreement with Vyome, under which ...
(RTTNews) - OS Therapies, Inc. (OSTX) Wednesday announced that it has entered into an asset purchase agreement to acquire the listeria monocytogenes-based immuno-oncology programs and related ...
a Delaware corporation, disclosed in a recent 8-K filing with the Securities and Exchange Commission that on January 16, 2025, it finalized an Asset Purchase Agreement with Fukuda Denshi Co., ...
Several combination treatment studies containing BRII-179 have quickly started to carry forward the Company's strategy for HBV functional cure "This transaction ensures us with uninterrupted ...
and other assets relating to BRII-179. Under the agreement, among other matters, the Company will fully acquire the BRII-179 patents, BRII-179 know-how, and relevant BRII-179 materials ...
Under the agreement, among other matters, the Company will fully acquire the BRII-179 patents, BRII-179 know-how, and relevant BRII-179 materials, eliminating all future milestones and royalty ...